Global Idiopathic Gastroparesis Drugs Market Research Report 2023

Report ID: 2009692 | Published Date: Jan 2025 | No. of Page: 85 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Idiopathic Gastroparesis Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Prokinetic Agents
        1.2.3 Antiemetic Agents
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Idiopathic Gastroparesis Drugs Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Private Clinics
        1.3.4 Drug Stores
        1.3.5 E-Commerce
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Idiopathic Gastroparesis Drugs Market Perspective (2017-2028)
    2.2 Idiopathic Gastroparesis Drugs Growth Trends by Region
        2.2.1 Idiopathic Gastroparesis Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Idiopathic Gastroparesis Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Idiopathic Gastroparesis Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Idiopathic Gastroparesis Drugs Market Dynamics
        2.3.1 Idiopathic Gastroparesis Drugs Industry Trends
        2.3.2 Idiopathic Gastroparesis Drugs Market Drivers
        2.3.3 Idiopathic Gastroparesis Drugs Market Challenges
        2.3.4 Idiopathic Gastroparesis Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Idiopathic Gastroparesis Drugs Players by Revenue
        3.1.1 Global Top Idiopathic Gastroparesis Drugs Players by Revenue (2017-2022)
        3.1.2 Global Idiopathic Gastroparesis Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Idiopathic Gastroparesis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Idiopathic Gastroparesis Drugs Revenue
    3.4 Global Idiopathic Gastroparesis Drugs Market Concentration Ratio
        3.4.1 Global Idiopathic Gastroparesis Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Idiopathic Gastroparesis Drugs Revenue in 2021
    3.5 Idiopathic Gastroparesis Drugs Key Players Head office and Area Served
    3.6 Key Players Idiopathic Gastroparesis Drugs Product Solution and Service
    3.7 Date of Enter into Idiopathic Gastroparesis Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Idiopathic Gastroparesis Drugs Breakdown Data by Type
    4.1 Global Idiopathic Gastroparesis Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Idiopathic Gastroparesis Drugs Forecasted Market Size by Type (2023-2028)
5 Idiopathic Gastroparesis Drugs Breakdown Data by Application
    5.1 Global Idiopathic Gastroparesis Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Idiopathic Gastroparesis Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Idiopathic Gastroparesis Drugs Market Size (2017-2028)
    6.2 North America Idiopathic Gastroparesis Drugs Market Size by Country (2017-2022)
    6.3 North America Idiopathic Gastroparesis Drugs Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Idiopathic Gastroparesis Drugs Market Size (2017-2028)
    7.2 Europe Idiopathic Gastroparesis Drugs Market Size by Country (2017-2022)
    7.3 Europe Idiopathic Gastroparesis Drugs Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Idiopathic Gastroparesis Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Idiopathic Gastroparesis Drugs Market Size by Country (2017-2022)
    8.3 Asia-Pacific Idiopathic Gastroparesis Drugs Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Idiopathic Gastroparesis Drugs Market Size (2017-2028)
    9.2 Latin America Idiopathic Gastroparesis Drugs Market Size by Country (2017-2022)
    9.3 Latin America Idiopathic Gastroparesis Drugs Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Idiopathic Gastroparesis Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Idiopathic Gastroparesis Drugs Market Size by Country (2017-2022)
    10.3 Middle East & Africa Idiopathic Gastroparesis Drugs Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Sumitomo
        11.1.1 Sumitomo Company Detail
        11.1.2 Sumitomo Business Overview
        11.1.3 Sumitomo Idiopathic Gastroparesis Drugs Introduction
        11.1.4 Sumitomo Revenue in Idiopathic Gastroparesis Drugs Business (2017-2022)
        11.1.5 Sumitomo Recent Development
    11.2 Cadila Pharmaceuticals
        11.2.1 Cadila Pharmaceuticals Company Detail
        11.2.2 Cadila Pharmaceuticals Business Overview
        11.2.3 Cadila Pharmaceuticals Idiopathic Gastroparesis Drugs Introduction
        11.2.4 Cadila Pharmaceuticals Revenue in Idiopathic Gastroparesis Drugs Business (2017-2022)
        11.2.5 Cadila Pharmaceuticals Recent Development
    11.3 Sanofi
        11.3.1 Sanofi Company Detail
        11.3.2 Sanofi Business Overview
        11.3.3 Sanofi Idiopathic Gastroparesis Drugs Introduction
        11.3.4 Sanofi Revenue in Idiopathic Gastroparesis Drugs Business (2017-2022)
        11.3.5 Sanofi Recent Development
    11.4 Teva
        11.4.1 Teva Company Detail
        11.4.2 Teva Business Overview
        11.4.3 Teva Idiopathic Gastroparesis Drugs Introduction
        11.4.4 Teva Revenue in Idiopathic Gastroparesis Drugs Business (2017-2022)
        11.4.5 Teva Recent Development
    11.5 Johnson & Johnson
        11.5.1 Johnson & Johnson Company Detail
        11.5.2 Johnson & Johnson Business Overview
        11.5.3 Johnson & Johnson Idiopathic Gastroparesis Drugs Introduction
        11.5.4 Johnson & Johnson Revenue in Idiopathic Gastroparesis Drugs Business (2017-2022)
        11.5.5 Johnson & Johnson Recent Development
    11.6 Pfizer
        11.6.1 Pfizer Company Detail
        11.6.2 Pfizer Business Overview
        11.6.3 Pfizer Idiopathic Gastroparesis Drugs Introduction
        11.6.4 Pfizer Revenue in Idiopathic Gastroparesis Drugs Business (2017-2022)
        11.6.5 Pfizer Recent Development
    11.7 Kyowa Kirin Pharmaceuticals
        11.7.1 Kyowa Kirin Pharmaceuticals Company Detail
        11.7.2 Kyowa Kirin Pharmaceuticals Business Overview
        11.7.3 Kyowa Kirin Pharmaceuticals Idiopathic Gastroparesis Drugs Introduction
        11.7.4 Kyowa Kirin Pharmaceuticals Revenue in Idiopathic Gastroparesis Drugs Business (2017-2022)
        11.7.5 Kyowa Kirin Pharmaceuticals Recent Development
    11.8 Hanmi Pharm
        11.8.1 Hanmi Pharm Company Detail
        11.8.2 Hanmi Pharm Business Overview
        11.8.3 Hanmi Pharm Idiopathic Gastroparesis Drugs Introduction
        11.8.4 Hanmi Pharm Revenue in Idiopathic Gastroparesis Drugs Business (2017-2022)
        11.8.5 Hanmi Pharm Recent Development
    11.9 Ani Pharmaceuticals
        11.9.1 Ani Pharmaceuticals Company Detail
        11.9.2 Ani Pharmaceuticals Business Overview
        11.9.3 Ani Pharmaceuticals Idiopathic Gastroparesis Drugs Introduction
        11.9.4 Ani Pharmaceuticals Revenue in Idiopathic Gastroparesis Drugs Business (2017-2022)
        11.9.5 Ani Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Idiopathic Gastroparesis Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Prokinetic Agents
    Table 3. Key Players of Antiemetic Agents
    Table 4. Key Players of Others
    Table 5. Global Idiopathic Gastroparesis Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Idiopathic Gastroparesis Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Idiopathic Gastroparesis Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Idiopathic Gastroparesis Drugs Market Share by Region (2017-2022)
    Table 9. Global Idiopathic Gastroparesis Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Idiopathic Gastroparesis Drugs Market Share by Region (2023-2028)
    Table 11. Idiopathic Gastroparesis Drugs Market Trends
    Table 12. Idiopathic Gastroparesis Drugs Market Drivers
    Table 13. Idiopathic Gastroparesis Drugs Market Challenges
    Table 14. Idiopathic Gastroparesis Drugs Market Restraints
    Table 15. Global Idiopathic Gastroparesis Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Idiopathic Gastroparesis Drugs Market Share by Players (2017-2022)
    Table 17. Global Top Idiopathic Gastroparesis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Idiopathic Gastroparesis Drugs as of 2021)
    Table 18. Ranking of Global Top Idiopathic Gastroparesis Drugs Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Idiopathic Gastroparesis Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Idiopathic Gastroparesis Drugs Product Solution and Service
    Table 22. Date of Enter into Idiopathic Gastroparesis Drugs Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Idiopathic Gastroparesis Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Idiopathic Gastroparesis Drugs Revenue Market Share by Type (2017-2022)
    Table 26. Global Idiopathic Gastroparesis Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Idiopathic Gastroparesis Drugs Revenue Market Share by Type (2023-2028)
    Table 28. Global Idiopathic Gastroparesis Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Idiopathic Gastroparesis Drugs Revenue Market Share by Application (2017-2022)
    Table 30. Global Idiopathic Gastroparesis Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Idiopathic Gastroparesis Drugs Revenue Market Share by Application (2023-2028)
    Table 32. North America Idiopathic Gastroparesis Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Idiopathic Gastroparesis Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Idiopathic Gastroparesis Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Idiopathic Gastroparesis Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Idiopathic Gastroparesis Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Idiopathic Gastroparesis Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Idiopathic Gastroparesis Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Idiopathic Gastroparesis Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Idiopathic Gastroparesis Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Idiopathic Gastroparesis Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Sumitomo Company Detail
    Table 43. Sumitomo Business Overview
    Table 44. Sumitomo Idiopathic Gastroparesis Drugs Product
    Table 45. Sumitomo Revenue in Idiopathic Gastroparesis Drugs Business (2017-2022) & (US$ Million)
    Table 46. Sumitomo Recent Development
    Table 47. Cadila Pharmaceuticals Company Detail
    Table 48. Cadila Pharmaceuticals Business Overview
    Table 49. Cadila Pharmaceuticals Idiopathic Gastroparesis Drugs Product
    Table 50. Cadila Pharmaceuticals Revenue in Idiopathic Gastroparesis Drugs Business (2017-2022) & (US$ Million)
    Table 51. Cadila Pharmaceuticals Recent Development
    Table 52. Sanofi Company Detail
    Table 53. Sanofi Business Overview
    Table 54. Sanofi Idiopathic Gastroparesis Drugs Product
    Table 55. Sanofi Revenue in Idiopathic Gastroparesis Drugs Business (2017-2022) & (US$ Million)
    Table 56. Sanofi Recent Development
    Table 57. Teva Company Detail
    Table 58. Teva Business Overview
    Table 59. Teva Idiopathic Gastroparesis Drugs Product
    Table 60. Teva Revenue in Idiopathic Gastroparesis Drugs Business (2017-2022) & (US$ Million)
    Table 61. Teva Recent Development
    Table 62. Johnson & Johnson Company Detail
    Table 63. Johnson & Johnson Business Overview
    Table 64. Johnson & Johnson Idiopathic Gastroparesis Drugs Product
    Table 65. Johnson & Johnson Revenue in Idiopathic Gastroparesis Drugs Business (2017-2022) & (US$ Million)
    Table 66. Johnson & Johnson Recent Development
    Table 67. Pfizer Company Detail
    Table 68. Pfizer Business Overview
    Table 69. Pfizer Idiopathic Gastroparesis Drugs Product
    Table 70. Pfizer Revenue in Idiopathic Gastroparesis Drugs Business (2017-2022) & (US$ Million)
    Table 71. Pfizer Recent Development
    Table 72. Kyowa Kirin Pharmaceuticals Company Detail
    Table 73. Kyowa Kirin Pharmaceuticals Business Overview
    Table 74. Kyowa Kirin Pharmaceuticals Idiopathic Gastroparesis Drugs Product
    Table 75. Kyowa Kirin Pharmaceuticals Revenue in Idiopathic Gastroparesis Drugs Business (2017-2022) & (US$ Million)
    Table 76. Kyowa Kirin Pharmaceuticals Recent Development
    Table 77. Hanmi Pharm Company Detail
    Table 78. Hanmi Pharm Business Overview
    Table 79. Hanmi Pharm Idiopathic Gastroparesis Drugs Product
    Table 80. Hanmi Pharm Revenue in Idiopathic Gastroparesis Drugs Business (2017-2022) & (US$ Million)
    Table 81. Hanmi Pharm Recent Development
    Table 82. Ani Pharmaceuticals Company Detail
    Table 83. Ani Pharmaceuticals Business Overview
    Table 84. Ani Pharmaceuticals Idiopathic Gastroparesis Drugs Product
    Table 85. Ani Pharmaceuticals Revenue in Idiopathic Gastroparesis Drugs Business (2017-2022) & (US$ Million)
    Table 86. Ani Pharmaceuticals Recent Development
    Table 87. Research Programs/Design for This Report
    Table 88. Key Data Information from Secondary Sources
    Table 89. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Idiopathic Gastroparesis Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Prokinetic Agents Features
    Figure 3. Antiemetic Agents Features
    Figure 4. Others Features
    Figure 5. Global Idiopathic Gastroparesis Drugs Market Share by Application in 2021 & 2028
    Figure 6. Hospital Pharmacies Case Studies
    Figure 7. Private Clinics Case Studies
    Figure 8. Drug Stores Case Studies
    Figure 9. E-Commerce Case Studies
    Figure 10. Idiopathic Gastroparesis Drugs Report Years Considered
    Figure 11. Global Idiopathic Gastroparesis Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Idiopathic Gastroparesis Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Idiopathic Gastroparesis Drugs Market Share by Region: 2021 VS 2028
    Figure 14. Global Idiopathic Gastroparesis Drugs Market Share by Players in 2021
    Figure 15. Global Top Idiopathic Gastroparesis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Idiopathic Gastroparesis Drugs as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Idiopathic Gastroparesis Drugs Revenue in 2021
    Figure 17. North America Idiopathic Gastroparesis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Idiopathic Gastroparesis Drugs Market Share by Country (2017-2028)
    Figure 19. United States Idiopathic Gastroparesis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Idiopathic Gastroparesis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Idiopathic Gastroparesis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Idiopathic Gastroparesis Drugs Market Share by Country (2017-2028)
    Figure 23. Germany Idiopathic Gastroparesis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Idiopathic Gastroparesis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Idiopathic Gastroparesis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Idiopathic Gastroparesis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Idiopathic Gastroparesis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Idiopathic Gastroparesis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Idiopathic Gastroparesis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Idiopathic Gastroparesis Drugs Market Share by Region (2017-2028)
    Figure 31. China Idiopathic Gastroparesis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Idiopathic Gastroparesis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Idiopathic Gastroparesis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Idiopathic Gastroparesis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Idiopathic Gastroparesis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Idiopathic Gastroparesis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Idiopathic Gastroparesis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Idiopathic Gastroparesis Drugs Market Share by Country (2017-2028)
    Figure 39. Mexico Idiopathic Gastroparesis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Idiopathic Gastroparesis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Idiopathic Gastroparesis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Idiopathic Gastroparesis Drugs Market Share by Country (2017-2028)
    Figure 43. Turkey Idiopathic Gastroparesis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Idiopathic Gastroparesis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Sumitomo Revenue Growth Rate in Idiopathic Gastroparesis Drugs Business (2017-2022)
    Figure 46. Cadila Pharmaceuticals Revenue Growth Rate in Idiopathic Gastroparesis Drugs Business (2017-2022)
    Figure 47. Sanofi Revenue Growth Rate in Idiopathic Gastroparesis Drugs Business (2017-2022)
    Figure 48. Teva Revenue Growth Rate in Idiopathic Gastroparesis Drugs Business (2017-2022)
    Figure 49. Johnson & Johnson Revenue Growth Rate in Idiopathic Gastroparesis Drugs Business (2017-2022)
    Figure 50. Pfizer Revenue Growth Rate in Idiopathic Gastroparesis Drugs Business (2017-2022)
    Figure 51. Kyowa Kirin Pharmaceuticals Revenue Growth Rate in Idiopathic Gastroparesis Drugs Business (2017-2022)
    Figure 52. Hanmi Pharm Revenue Growth Rate in Idiopathic Gastroparesis Drugs Business (2017-2022)
    Figure 53. Ani Pharmaceuticals Revenue Growth Rate in Idiopathic Gastroparesis Drugs Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sumitomo
Cadila Pharmaceuticals
Sanofi
Teva
Johnson & Johnson
Pfizer
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Ani Pharmaceuticals
Frequently Asked Questions
Idiopathic Gastroparesis Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Idiopathic Gastroparesis Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Idiopathic Gastroparesis Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports